ArticleCell death & disease2021

Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction.

HuiYa Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.